Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Neurocysticercosis: pediatric aspects]

J Grill1, P Pillet, W Rakotomalala

  • 1Service de pédiatrie, centre hospitalier de Soavinandriana, Antananarivo, Madagascar.

Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie
|April 1, 1996
PubMed
Summary

Neurocysticercosis, a common parasitic brain infection, is increasingly diagnosed globally due to migration. Early diagnosis and treatment are crucial for managing neurological symptoms like epilepsy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Real life data of ONC201 (dordaviprone) in pediatric and adult H3K27-altered recurrent diffuse midline glioma: Results of an international academia-driven compassionate use program.

European journal of cancer (Oxford, England : 1990)·2024
Same author

Exploring Memory Systems After Pediatric Posterior Fossa Tumor: From Memory Profile Comparisons in Nonirradiated Versus Irradiated Patients to Episodic Memory Tests Capable of Detecting Radiation-induced Hippocampal Damage.

Clinical oncology (Royal College of Radiologists (Great Britain))·2024
Same author

Unravelling the clinical heterogeneity of undefined recurrent fever over time in the European registries on Autoinflammation.

Pediatric rheumatology online journal·2024
Same author

An academia-driven compassionate use program for patients with recurrent H3K27-altered diffuse midline glioma: a new way to access innovation when clinical trials are lacking.

Annals of oncology : official journal of the European Society for Medical Oncology·2023
Same author

[Transition from pediatric to adult care: Recommendations of the French network for autoimmune and autoinflammatory diseases (FAI<sup>2</sup>R)].

La Revue de medecine interne·2021
Same author

EZHIP is a specific diagnostic biomarker for posterior fossa ependymomas, group PFA and diffuse midline gliomas H3-WT with EZHIP overexpression.

Acta neuropathologica communications·2020

Area of Science:

  • Neurology
  • Infectious Diseases
  • Parasitology

Context:

  • Neurocysticercosis is the most common parasitic infection of the central nervous system worldwide.
  • Increasing migration from endemic areas leads to more frequent diagnoses in non-endemic regions like France.
  • Epilepsy is the primary presenting symptom, but any neurological sign warrants suspicion in endemic areas.

Purpose:

  • To provide a comprehensive overview of neurocysticercosis, including its epidemiology, clinical presentation, diagnosis, and management.
  • To highlight the growing importance of neurocysticercosis in public health due to global travel and migration.
  • To inform healthcare professionals about the diagnostic and therapeutic challenges posed by this parasitic infection.

Summary:

  • Diagnosis relies on neuroimaging (CT, MRI) and serological tests (ELISA, Western blot).

Related Experiment Videos

  • Clinical presentation varies widely, from asymptomatic cases to severe encephalopathy.
  • Treatment involves antiparasitic drugs (praziquantel, albendazole), corticosteroids for acute symptoms, and potentially neurosurgery for severe forms.

    • Impact:

    • Improved diagnostic strategies and timely treatment can significantly alter the disease's course, reducing morbidity and mortality.
    • Public health initiatives focusing on prevention, such as health education campaigns in endemic regions, are vital.
    • The development of an effective vaccine remains a long-term goal for disease eradication.